Naokazu Ibuki

Osaka Medical and Pharmaceutical University

Papers

1

Total Citations

48

H-Index

1

About

Dr. Naokazu Ibuki is a leading urologic surgeon and researcher whose work centers on advancing minimally invasive surgical techniques for renal cancer treatment. His primary research focus is the comparative effectiveness of robot-assisted versus laparoscopic partial nephrectomy, particularly for complex renal hilar tumors—a challenging surgical scenario where preserving kidney function while achieving complete tumor removal is critical. Dr. Ibuki’s most notable contribution is his landmark prospective, multi-institutional study published in 2020, which demonstrated that robot-assisted partial nephrectomy offers significant advantages over standard laparoscopic approaches for hilar tumors. This pivotal work, cited 48 times, provides robust evidence from 22 academic hospitals, establishing a new benchmark for surgical decision-making in nephron-sparing surgery. By systematically evaluating outcomes in this high-risk patient population, Dr. Ibuki has directly influenced clinical guidelines and helped shape modern urologic oncology practice. His rigorous trial design and commitment to multi-center collaboration underscore his reputation as a meticulous investigator dedicated to improving surgical precision and patient outcomes in renal cell carcinoma management.

Research Focus

Key Achievements

1
H-Index
1
Papers
48
Total Citations
48
Avg Citations/Paper
🏆 Most Cited Paper
Robot‐assisted partial nephrectomy versus standard laparoscopic partial nephrectomy for renal hilar tumor: A prospective multi‐institutional study
48 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 21
🏛 Institutions: Osaka Medical and Pharmaceutical University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago